Stock STIM NEURONETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 21:00:00 30/04/2024 BST 		5-day change 1st Jan Change
3.37 USD -4.67% Intraday chart for Neuronetics, Inc. -12.69% +16.21%
04-10 Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation CI
03-28 Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board CI

Business Summary

Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Number of employees: 203

Sales per Business

USD in Million2022Weight2023Weight Delta
Treatment Sessions
72.4 %
45 69.7 % 52 72.4 % +13.69%
NeuroStar Advanced Therapy System
24.0 %
17 26.7 % 17 24.0 % -1.71%
Other
3.7 %
2 3.7 % 3 3.7 % +9.21%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
97.2 %
63 97.2 % 69 97.2 % +9.35%
International
2.8 %
2 2.8 % 2 2.8 % +11.78%

Managers

Managers TitleAgeSince
Keith Sullivan CEO
 Chief Executive Officer 66 13/07/20
Stephen Furlong DFI
 Director of Finance/CFO 60 -
Cory Anderson CTO
 Chief Tech/Sci/R&D Officer - 28/02/21
W. Macan CMP
 Compliance Officer 51 20/01/20
Lisa Metzner-Rosas SAM
 Sales & Marketing - 30/04/23
Rick Grubbs AUD
 Comptroller/Controller/Auditor - -
Sara Grubbs PRN
 Corporate Officer/Principal - 04/10/20
Todd Cushman PRN
 Corporate Officer/Principal - 31/05/21

Members of the board

Members of the board TitleAgeSince
Robert Cascella CHM
 Chairman 69 31/03/21
Sheryl Conley BRD
 Director/Board Member 63 30/09/19
Wilfred Jaeger BRD
 Director/Board Member 67 30/04/05
John Bakewell BRD
 Director/Board Member 62 31/03/20
Glenn Muir BRD
 Director/Board Member 65 30/06/17
Keith Sullivan CEO
 Chief Executive Officer 66 13/07/20
Joe Capper BRD
 Director/Board Member 60 31/12/22
Megan Rosengarten BRD
 Director/Board Member 47 01/08/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,974,617 28,080,775 ( 93.68 %) 0 93.68 %

Shareholders

NameEquities%Valuation
Cannell Capital LLC
9.307 %
2,769,268 9.307 % 13 M $
Archon Capital Management LLC
8.526 %
2,537,097 8.526 % 12 M $
Divisadero Street Capital Management LP
5.173 %
1,539,382 5.173 % 7 M $
Balyasny Asset Management LP
4.764 %
1,417,722 4.764 % 7 M $
Keith Sullivan
4.612 %
1,372,278 4.612 % 7 M $
Vanguard Global Advisers LLC
4.547 %
1,353,144 4.547 % 6 M $
SILVERCREST ASSET MANAGEMENT GROUP INC.
3.786 %
1,126,484 3.786 % 5 M $
Kent Lake Capital LLC
3.751 %
1,116,041 3.751 % 5 M $
First Eagle Investment Management LLC
2.608 %
776,009 2.608 % 4 M $
Parian Global Management LP
2.555 %
760,410 2.555 % 4 M $

Company contact information

Neuronetics, Inc.

3222 Phoenixville Pike

19355, Malvern

+610 640 4202

http://www.neuronetics.com
address Neuronetics, Inc.(STIM)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Advanced Medical Equipment & Technology
Other Advanced Medical Equipment & Technology

Sales per Business

Sales per region

Ratings for Neuronetics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3.37 USD
Average target price
7 USD
Spread / Average Target
+107.72%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
NEURONETICS, INC. Stock Neuronetics, Inc.
+16.21% 106M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.15% 220B
DANAHER CORPORATION Stock Danaher Corporation
+6.60% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+9.86% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+24.32% 107B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.95% 63.05B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.04% 51.74B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.47B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-1.43% 40.91B
RESMED, INC. Stock ResMed, Inc.
+24.40% 31.91B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. STIM Stock
  4. Company Neuronetics, Inc.